A daily pill, Kisqali is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor that prevents cancer cells from dividing and growing. This kind of drug is taken with an aromatase inhibitor ...
coming in at 90.4% for Kisqali and 87.1% for endocrine therapy, but represented a significant improvement for Novartis’ drug, according to lead investigator Dennis Slamon of UCLA Jonsson ...
Copyright: © 2024 Elsevier Ltd. Published by Elsevier Ltd. Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important ...
Using drugs changes a person's brain structure and functioning, particularly in areas involved in reward, stress, and self-control. These alterations make it harder for people to stop using substances ...
This is the most recent version of the national Cancer Drugs Fund list, and replaces any earlier versions. It contains updates to the previous list, as well as new drugs and indications which have ...
Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...
Verapamil is a prescription medication available under the brand name Verelan and as a generic drug. While not approved by the U.S. Food and Drug Administration (FDA) for migraine prevention, it may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback